NEW YORK, Nov. 30, 2016 /PRNewswire/ -- Rosen Law Firm, a
global investor rights law firm, reminds purchasers of Cempra,
Inc. securities (NASDAQ: CEMP) from May
1, 2016 through November 1,
2016, both dates inclusive (the "Class Period") of the
important January 3, 2017 lead
plaintiff deadline in the class action. The lawsuit seeks to
recover damages for Cempra investors under the federal securities
laws.
To join the Cempra class action, go to
http://www.rosenlegal.com/cases-985.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or
email pkim@rosenlegal.com or kchan@rosenlegal.com for information
on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants
issued false and misleading statements to investors and/or failed
to disclose that: (1) one of Cempra's lead product candidate,
solithromycin, posed significant safety risks for hepatotoxicity;
and (2) as a result of the foregoing, Cempra's public statements
were materially false and misleading at all relevant times. When
the true details entered the market, the lawsuit claims that
investors suffered damages.
A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than
January 3, 2017. A lead plaintiff is
a representative party acting on behalf of other class members in
directing the litigation. If you wish to join the litigation, go to
http://www.rosenlegal.com/cases-985.html or to discuss your rights
or interests regarding this class action, please contact
Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at
866-767-3653 or via e-mail at pkim@rosenlegal.com or
kchan@rosenlegal.com. Attorney Advertising. Prior results do not
guarantee a similar outcome.
Follow us for updates on LinkedIn:
https://www.linkedin.com/company/the-rosen-law-firm or on Twitter:
https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Contact Information:
Laurence
Rosen, Esq.
Phillip Kim,
Esq.
Kevin Chan,
Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th
Floor
New York,
NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com
Logo - http://photos.prnewswire.com/prnh/20160907/405060LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/rosen-law-firm-reminds-cempra-inc-investors-of-important-deadline-in-class-action---cemp-300371029.html
SOURCE Rosen Law Firm, P.A.